Global Surgical Hemostatic Agents Market Research Report 2023
Hemostasis, also known as hemorrhage prevention, is the process that stops blood from leaking into a blood vessel. Hemostasis happens when a clot develops at the location of the blood vessel injury, repairing it. This report mainly focuses on surgical hemostatic agents market.
According to QYResearch’s new survey, global Surgical Hemostatic Agents market is projected to reach US$ 5746.2 million in 2029, increasing from US$ 3975 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Surgical Hemostatic Agents market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Surgical Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
According to QYResearch’s new survey, global Surgical Hemostatic Agents market is projected to reach US$ 5746.2 million in 2029, increasing from US$ 3975 million in 2022, with the CAGR of 5.8% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Surgical Hemostatic Agents market research.
According to our research, the global market for medical devices is estimated at US$ 603 billion in the year 2023, and will be growing at a CAGR of 5% during next six years. The global healthcare spending contributes to occupy 10% of the global GDP and is continuously rising in recent years due to the increasing health needs of the aging population, the growing prevalence of chronic and infectious diseases and the expansion of emerging markets. The medical devices market plays a significant role in the healthcare industry. The market is driven by several factors, including the increasing demand for advanced healthcare services globally, advancements in medical technology, growing geriatric population, rising healthcare expenditure, and increasing awareness about early disease diagnosis and treatment.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Surgical Hemostatic Agents market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
- J&J
- Baxter
- BD
- Gelita
- Pfizer
- B Braun
- CSL Behring
- Ferrosan Medical Devices
- Advance Medical Solution
- Medtronic
- Z-Medica
- Marine Polymer
- Equimedical
- CryoLife
- Gelation Hemostats
- Combination Hemostats
- Others
- Hospitals
- Surgical Centers
- Other
- North America
- United States
- Canada
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Asia-Pacific
- China
- Japan
- South Korea
- India
- Australia
- China Taiwan
- Indonesia
- Thailand
- Malaysia
- Latin America
- Mexico
- Brazil
- Argentina
- Colombia
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Manufacturers’ Competition Patterns
Chapter 3: Country Level Sales Analysis
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6: Manufacturers’ Outline
Chapter 7: Industry Chain, Market Channel and Customer Analysis
Chapter 8: Market Opportunities and Challenges
Chapter 9: Market Conclusions
Chapter 10: Research Methodology and Data Source
1 SURGICAL HEMOSTATIC AGENTS MARKET OVERVIEW
1.1 Product Overview and Scope of Surgical Hemostatic Agents
1.2 Surgical Hemostatic Agents Segment by Type
1.2.1 Global Surgical Hemostatic Agents Market Value Comparison by Type (2023-2029)
1.2.2 Gelation Hemostats
1.2.3 Combination Hemostats
1.2.4 Others
1.3 Surgical Hemostatic Agents Segment by Application
1.3.1 Global Surgical Hemostatic Agents Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Other
1.4 Global Surgical Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Surgical Hemostatic Agents Revenue 2018-2029
1.4.2 Global Surgical Hemostatic Agents Sales 2018-2029
1.4.3 Global Surgical Hemostatic Agents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 SURGICAL HEMOSTATIC AGENTS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Surgical Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Surgical Hemostatic Agents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Surgical Hemostatic Agents Average Price by Manufacturers (2018-2023)
2.4 Global Surgical Hemostatic Agents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Surgical Hemostatic Agents, Product Type & Application
2.7 Surgical Hemostatic Agents Market Competitive Situation and Trends
2.7.1 Surgical Hemostatic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Surgical Hemostatic Agents Players Market Share by Revenue
2.7.3 Global Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 SURGICAL HEMOSTATIC AGENTS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Surgical Hemostatic Agents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Surgical Hemostatic Agents Global Surgical Hemostatic Agents Sales by Region: 2018-2029
3.2.1 Global Surgical Hemostatic Agents Sales by Region: 2018-2023
3.2.2 Global Surgical Hemostatic Agents Sales by Region: 2024-2029
3.3 Global Surgical Hemostatic Agents Global Surgical Hemostatic Agents Revenue by Region: 2018-2029
3.3.1 Global Surgical Hemostatic Agents Revenue by Region: 2018-2023
3.3.2 Global Surgical Hemostatic Agents Revenue by Region: 2024-2029
3.4 North America Surgical Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Surgical Hemostatic Agents Sales by Country (2018-2029)
3.4.3 North America Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Surgical Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Surgical Hemostatic Agents Sales by Country (2018-2029)
3.5.3 Europe Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Surgical Hemostatic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Surgical Hemostatic Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Surgical Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Surgical Hemostatic Agents Sales by Country (2018-2029)
3.7.3 Latin America Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Surgical Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Surgical Hemostatic Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Surgical Hemostatic Agents Sales by Type (2018-2029)
4.1.1 Global Surgical Hemostatic Agents Sales by Type (2018-2023)
4.1.2 Global Surgical Hemostatic Agents Sales by Type (2024-2029)
4.1.3 Global Surgical Hemostatic Agents Sales Market Share by Type (2018-2029)
4.2 Global Surgical Hemostatic Agents Revenue by Type (2018-2029)
4.2.1 Global Surgical Hemostatic Agents Revenue by Type (2018-2023)
4.2.2 Global Surgical Hemostatic Agents Revenue by Type (2024-2029)
4.2.3 Global Surgical Hemostatic Agents Revenue Market Share by Type (2018-2029)
4.3 Global Surgical Hemostatic Agents Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Surgical Hemostatic Agents Sales by Application (2018-2029)
5.1.1 Global Surgical Hemostatic Agents Sales by Application (2018-2023)
5.1.2 Global Surgical Hemostatic Agents Sales by Application (2024-2029)
5.1.3 Global Surgical Hemostatic Agents Sales Market Share by Application (2018-2029)
5.2 Global Surgical Hemostatic Agents Revenue by Application (2018-2029)
5.2.1 Global Surgical Hemostatic Agents Revenue by Application (2018-2023)
5.2.2 Global Surgical Hemostatic Agents Revenue by Application (2024-2029)
5.2.3 Global Surgical Hemostatic Agents Revenue Market Share by Application (2018-2029)
5.3 Global Surgical Hemostatic Agents Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 J&J
6.1.1 J&J Corporation Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 J&J Surgical Hemostatic Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Surgical Hemostatic Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Surgical Hemostatic Agents Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Gelita
6.4.1 Gelita Corporation Information
6.4.2 Gelita Description and Business Overview
6.4.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Gelita Surgical Hemostatic Agents Product Portfolio
6.4.5 Gelita Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Surgical Hemostatic Agents Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 B Braun
6.6.1 B Braun Corporation Information
6.6.2 B Braun Description and Business Overview
6.6.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 B Braun Surgical Hemostatic Agents Product Portfolio
6.6.5 B Braun Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CSL Behring Surgical Hemostatic Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Ferrosan Medical Devices
6.8.1 Ferrosan Medical Devices Corporation Information
6.8.2 Ferrosan Medical Devices Description and Business Overview
6.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio
6.8.5 Ferrosan Medical Devices Recent Developments/Updates
6.9 Advance Medical Solution
6.9.1 Advance Medical Solution Corporation Information
6.9.2 Advance Medical Solution Description and Business Overview
6.9.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Advance Medical Solution Surgical Hemostatic Agents Product Portfolio
6.9.5 Advance Medical Solution Recent Developments/Updates
6.10 Medtronic
6.10.1 Medtronic Corporation Information
6.10.2 Medtronic Description and Business Overview
6.10.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medtronic Surgical Hemostatic Agents Product Portfolio
6.10.5 Medtronic Recent Developments/Updates
6.11 Z-Medica
6.11.1 Z-Medica Corporation Information
6.11.2 Z-Medica Surgical Hemostatic Agents Description and Business Overview
6.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Z-Medica Surgical Hemostatic Agents Product Portfolio
6.11.5 Z-Medica Recent Developments/Updates
6.12 Marine Polymer
6.12.1 Marine Polymer Corporation Information
6.12.2 Marine Polymer Surgical Hemostatic Agents Description and Business Overview
6.12.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Marine Polymer Surgical Hemostatic Agents Product Portfolio
6.12.5 Marine Polymer Recent Developments/Updates
6.13 Equimedical
6.13.1 Equimedical Corporation Information
6.13.2 Equimedical Surgical Hemostatic Agents Description and Business Overview
6.13.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Equimedical Surgical Hemostatic Agents Product Portfolio
6.13.5 Equimedical Recent Developments/Updates
6.14 CryoLife
6.14.1 CryoLife Corporation Information
6.14.2 CryoLife Surgical Hemostatic Agents Description and Business Overview
6.14.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CryoLife Surgical Hemostatic Agents Product Portfolio
6.14.5 CryoLife Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Surgical Hemostatic Agents Industry Chain Analysis
7.2 Surgical Hemostatic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Surgical Hemostatic Agents Production Mode & Process
7.4 Surgical Hemostatic Agents Sales and Marketing
7.4.1 Surgical Hemostatic Agents Sales Channels
7.4.2 Surgical Hemostatic Agents Distributors
7.5 Surgical Hemostatic Agents Customers
8 SURGICAL HEMOSTATIC AGENTS MARKET DYNAMICS
8.1 Surgical Hemostatic Agents Industry Trends
8.2 Surgical Hemostatic Agents Market Drivers
8.3 Surgical Hemostatic Agents Market Challenges
8.4 Surgical Hemostatic Agents Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
1.1 Product Overview and Scope of Surgical Hemostatic Agents
1.2 Surgical Hemostatic Agents Segment by Type
1.2.1 Global Surgical Hemostatic Agents Market Value Comparison by Type (2023-2029)
1.2.2 Gelation Hemostats
1.2.3 Combination Hemostats
1.2.4 Others
1.3 Surgical Hemostatic Agents Segment by Application
1.3.1 Global Surgical Hemostatic Agents Market Value by Application: (2023-2029)
1.3.2 Hospitals
1.3.3 Surgical Centers
1.3.4 Other
1.4 Global Surgical Hemostatic Agents Market Size Estimates and Forecasts
1.4.1 Global Surgical Hemostatic Agents Revenue 2018-2029
1.4.2 Global Surgical Hemostatic Agents Sales 2018-2029
1.4.3 Global Surgical Hemostatic Agents Market Average Price (2018-2029)
1.5 Assumptions and Limitations
2 SURGICAL HEMOSTATIC AGENTS MARKET COMPETITION BY MANUFACTURERS
2.1 Global Surgical Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
2.2 Global Surgical Hemostatic Agents Revenue Market Share by Manufacturers (2018-2023)
2.3 Global Surgical Hemostatic Agents Average Price by Manufacturers (2018-2023)
2.4 Global Surgical Hemostatic Agents Industry Ranking 2021 VS 2022 VS 2023
2.5 Global Key Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
2.6 Global Key Manufacturers of Surgical Hemostatic Agents, Product Type & Application
2.7 Surgical Hemostatic Agents Market Competitive Situation and Trends
2.7.1 Surgical Hemostatic Agents Market Concentration Rate
2.7.2 The Global Top 5 and Top 10 Largest Surgical Hemostatic Agents Players Market Share by Revenue
2.7.3 Global Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.8 Manufacturers Mergers & Acquisitions, Expansion Plans
3 SURGICAL HEMOSTATIC AGENTS RETROSPECTIVE MARKET SCENARIO BY REGION
3.1 Global Surgical Hemostatic Agents Market Size by Region: 2018 Versus 2022 Versus 2029
3.2 Global Surgical Hemostatic Agents Global Surgical Hemostatic Agents Sales by Region: 2018-2029
3.2.1 Global Surgical Hemostatic Agents Sales by Region: 2018-2023
3.2.2 Global Surgical Hemostatic Agents Sales by Region: 2024-2029
3.3 Global Surgical Hemostatic Agents Global Surgical Hemostatic Agents Revenue by Region: 2018-2029
3.3.1 Global Surgical Hemostatic Agents Revenue by Region: 2018-2023
3.3.2 Global Surgical Hemostatic Agents Revenue by Region: 2024-2029
3.4 North America Surgical Hemostatic Agents Market Facts & Figures by Country
3.4.1 North America Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.4.2 North America Surgical Hemostatic Agents Sales by Country (2018-2029)
3.4.3 North America Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.4.4 United States
3.4.5 Canada
3.5 Europe Surgical Hemostatic Agents Market Facts & Figures by Country
3.5.1 Europe Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.5.2 Europe Surgical Hemostatic Agents Sales by Country (2018-2029)
3.5.3 Europe Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Surgical Hemostatic Agents Market Facts & Figures by Country
3.6.1 Asia Pacific Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.6.2 Asia Pacific Surgical Hemostatic Agents Sales by Country (2018-2029)
3.6.3 Asia Pacific Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Indonesia
3.6.11 Thailand
3.6.12 Malaysia
3.7 Latin America Surgical Hemostatic Agents Market Facts & Figures by Country
3.7.1 Latin America Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.7.2 Latin America Surgical Hemostatic Agents Sales by Country (2018-2029)
3.7.3 Latin America Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Surgical Hemostatic Agents Market Facts & Figures by Country
3.8.1 Middle East and Africa Surgical Hemostatic Agents Market Size by Country: 2018 VS 2022 VS 2029
3.8.2 Middle East and Africa Surgical Hemostatic Agents Sales by Country (2018-2029)
3.8.3 Middle East and Africa Surgical Hemostatic Agents Revenue by Country (2018-2029)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 SEGMENT BY TYPE
4.1 Global Surgical Hemostatic Agents Sales by Type (2018-2029)
4.1.1 Global Surgical Hemostatic Agents Sales by Type (2018-2023)
4.1.2 Global Surgical Hemostatic Agents Sales by Type (2024-2029)
4.1.3 Global Surgical Hemostatic Agents Sales Market Share by Type (2018-2029)
4.2 Global Surgical Hemostatic Agents Revenue by Type (2018-2029)
4.2.1 Global Surgical Hemostatic Agents Revenue by Type (2018-2023)
4.2.2 Global Surgical Hemostatic Agents Revenue by Type (2024-2029)
4.2.3 Global Surgical Hemostatic Agents Revenue Market Share by Type (2018-2029)
4.3 Global Surgical Hemostatic Agents Price by Type (2018-2029)
5 SEGMENT BY APPLICATION
5.1 Global Surgical Hemostatic Agents Sales by Application (2018-2029)
5.1.1 Global Surgical Hemostatic Agents Sales by Application (2018-2023)
5.1.2 Global Surgical Hemostatic Agents Sales by Application (2024-2029)
5.1.3 Global Surgical Hemostatic Agents Sales Market Share by Application (2018-2029)
5.2 Global Surgical Hemostatic Agents Revenue by Application (2018-2029)
5.2.1 Global Surgical Hemostatic Agents Revenue by Application (2018-2023)
5.2.2 Global Surgical Hemostatic Agents Revenue by Application (2024-2029)
5.2.3 Global Surgical Hemostatic Agents Revenue Market Share by Application (2018-2029)
5.3 Global Surgical Hemostatic Agents Price by Application (2018-2029)
6 KEY COMPANIES PROFILED
6.1 J&J
6.1.1 J&J Corporation Information
6.1.2 J&J Description and Business Overview
6.1.3 J&J Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.1.4 J&J Surgical Hemostatic Agents Product Portfolio
6.1.5 J&J Recent Developments/Updates
6.2 Baxter
6.2.1 Baxter Corporation Information
6.2.2 Baxter Description and Business Overview
6.2.3 Baxter Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.2.4 Baxter Surgical Hemostatic Agents Product Portfolio
6.2.5 Baxter Recent Developments/Updates
6.3 BD
6.3.1 BD Corporation Information
6.3.2 BD Description and Business Overview
6.3.3 BD Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.3.4 BD Surgical Hemostatic Agents Product Portfolio
6.3.5 BD Recent Developments/Updates
6.4 Gelita
6.4.1 Gelita Corporation Information
6.4.2 Gelita Description and Business Overview
6.4.3 Gelita Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 Gelita Surgical Hemostatic Agents Product Portfolio
6.4.5 Gelita Recent Developments/Updates
6.5 Pfizer
6.5.1 Pfizer Corporation Information
6.5.2 Pfizer Description and Business Overview
6.5.3 Pfizer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.5.4 Pfizer Surgical Hemostatic Agents Product Portfolio
6.5.5 Pfizer Recent Developments/Updates
6.6 B Braun
6.6.1 B Braun Corporation Information
6.6.2 B Braun Description and Business Overview
6.6.3 B Braun Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.6.4 B Braun Surgical Hemostatic Agents Product Portfolio
6.6.5 B Braun Recent Developments/Updates
6.7 CSL Behring
6.6.1 CSL Behring Corporation Information
6.6.2 CSL Behring Description and Business Overview
6.6.3 CSL Behring Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.4.4 CSL Behring Surgical Hemostatic Agents Product Portfolio
6.7.5 CSL Behring Recent Developments/Updates
6.8 Ferrosan Medical Devices
6.8.1 Ferrosan Medical Devices Corporation Information
6.8.2 Ferrosan Medical Devices Description and Business Overview
6.8.3 Ferrosan Medical Devices Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.8.4 Ferrosan Medical Devices Surgical Hemostatic Agents Product Portfolio
6.8.5 Ferrosan Medical Devices Recent Developments/Updates
6.9 Advance Medical Solution
6.9.1 Advance Medical Solution Corporation Information
6.9.2 Advance Medical Solution Description and Business Overview
6.9.3 Advance Medical Solution Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.9.4 Advance Medical Solution Surgical Hemostatic Agents Product Portfolio
6.9.5 Advance Medical Solution Recent Developments/Updates
6.10 Medtronic
6.10.1 Medtronic Corporation Information
6.10.2 Medtronic Description and Business Overview
6.10.3 Medtronic Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.10.4 Medtronic Surgical Hemostatic Agents Product Portfolio
6.10.5 Medtronic Recent Developments/Updates
6.11 Z-Medica
6.11.1 Z-Medica Corporation Information
6.11.2 Z-Medica Surgical Hemostatic Agents Description and Business Overview
6.11.3 Z-Medica Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.11.4 Z-Medica Surgical Hemostatic Agents Product Portfolio
6.11.5 Z-Medica Recent Developments/Updates
6.12 Marine Polymer
6.12.1 Marine Polymer Corporation Information
6.12.2 Marine Polymer Surgical Hemostatic Agents Description and Business Overview
6.12.3 Marine Polymer Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.12.4 Marine Polymer Surgical Hemostatic Agents Product Portfolio
6.12.5 Marine Polymer Recent Developments/Updates
6.13 Equimedical
6.13.1 Equimedical Corporation Information
6.13.2 Equimedical Surgical Hemostatic Agents Description and Business Overview
6.13.3 Equimedical Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.13.4 Equimedical Surgical Hemostatic Agents Product Portfolio
6.13.5 Equimedical Recent Developments/Updates
6.14 CryoLife
6.14.1 CryoLife Corporation Information
6.14.2 CryoLife Surgical Hemostatic Agents Description and Business Overview
6.14.3 CryoLife Surgical Hemostatic Agents Sales, Revenue and Gross Margin (2018-2023)
6.14.4 CryoLife Surgical Hemostatic Agents Product Portfolio
6.14.5 CryoLife Recent Developments/Updates
7 INDUSTRY CHAIN AND SALES CHANNELS ANALYSIS
7.1 Surgical Hemostatic Agents Industry Chain Analysis
7.2 Surgical Hemostatic Agents Key Raw Materials
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Surgical Hemostatic Agents Production Mode & Process
7.4 Surgical Hemostatic Agents Sales and Marketing
7.4.1 Surgical Hemostatic Agents Sales Channels
7.4.2 Surgical Hemostatic Agents Distributors
7.5 Surgical Hemostatic Agents Customers
8 SURGICAL HEMOSTATIC AGENTS MARKET DYNAMICS
8.1 Surgical Hemostatic Agents Industry Trends
8.2 Surgical Hemostatic Agents Market Drivers
8.3 Surgical Hemostatic Agents Market Challenges
8.4 Surgical Hemostatic Agents Market Restraints
9 RESEARCH FINDING AND CONCLUSION
10 METHODOLOGY AND DATA SOURCE
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
LIST OF TABLES
Table 1. Global Surgical Hemostatic Agents Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Surgical Hemostatic Agents Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Surgical Hemostatic Agents Market Competitive Situation by Manufacturers in 2022
Table 4. Global Surgical Hemostatic Agents Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Surgical Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Surgical Hemostatic Agents Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Surgical Hemostatic Agents Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Surgical Hemostatic Agents Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Surgical Hemostatic Agents, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Surgical Hemostatic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Surgical Hemostatic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Surgical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostatic Agents as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Surgical Hemostatic Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Surgical Hemostatic Agents Sales by Region (2018-2023) & (K Units)
Table 18. Global Surgical Hemostatic Agents Sales Market Share by Region (2018-2023)
Table 19. Global Surgical Hemostatic Agents Sales by Region (2024-2029) & (K Units)
Table 20. Global Surgical Hemostatic Agents Sales Market Share by Region (2024-2029)
Table 21. Global Surgical Hemostatic Agents Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Surgical Hemostatic Agents Revenue Market Share by Region (2018-2023)
Table 23. Global Surgical Hemostatic Agents Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Surgical Hemostatic Agents Revenue Market Share by Region (2024-2029)
Table 25. North America Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 27. North America Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 28. North America Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 32. Europe Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 33. Europe Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Surgical Hemostatic Agents Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Surgical Hemostatic Agents Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Surgical Hemostatic Agents Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Surgical Hemostatic Agents Sales (K Units) by Type (2018-2023)
Table 51. Global Surgical Hemostatic Agents Sales (K Units) by Type (2024-2029)
Table 52. Global Surgical Hemostatic Agents Sales Market Share by Type (2018-2023)
Table 53. Global Surgical Hemostatic Agents Sales Market Share by Type (2024-2029)
Table 54. Global Surgical Hemostatic Agents Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Surgical Hemostatic Agents Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Surgical Hemostatic Agents Revenue Market Share by Type (2018-2023)
Table 57. Global Surgical Hemostatic Agents Revenue Market Share by Type (2024-2029)
Table 58. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2018-2023)
Table 59. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2024-2029)
Table 60. Global Surgical Hemostatic Agents Sales (K Units) by Application (2018-2023)
Table 61. Global Surgical Hemostatic Agents Sales (K Units) by Application (2024-2029)
Table 62. Global Surgical Hemostatic Agents Sales Market Share by Application (2018-2023)
Table 63. Global Surgical Hemostatic Agents Sales Market Share by Application (2024-2029)
Table 64. Global Surgical Hemostatic Agents Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Surgical Hemostatic Agents Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Surgical Hemostatic Agents Revenue Market Share by Application (2018-2023)
Table 67. Global Surgical Hemostatic Agents Revenue Market Share by Application (2024-2029)
Table 68. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2018-2023)
Table 69. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2024-2029)
Table 70. J&J Corporation Information
Table 71. J&J Description and Business Overview
Table 72. J&J Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. J&J Surgical Hemostatic Agents Product
Table 74. J&J Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Baxter Surgical Hemostatic Agents Product
Table 79. Baxter Recent Developments/Updates
Table 80. BD Corporation Information
Table 81. BD Description and Business Overview
Table 82. BD Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. BD Surgical Hemostatic Agents Product
Table 84. BD Recent Developments/Updates
Table 85. Gelita Corporation Information
Table 86. Gelita Description and Business Overview
Table 87. Gelita Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Gelita Surgical Hemostatic Agents Product
Table 89. Gelita Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Surgical Hemostatic Agents Product
Table 94. Pfizer Recent Developments/Updates
Table 95. B Braun Corporation Information
Table 96. B Braun Description and Business Overview
Table 97. B Braun Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. B Braun Surgical Hemostatic Agents Product
Table 99. B Braun Recent Developments/Updates
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CSL Behring Surgical Hemostatic Agents Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. Ferrosan Medical Devices Corporation Information
Table 106. Ferrosan Medical Devices Description and Business Overview
Table 107. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Ferrosan Medical Devices Surgical Hemostatic Agents Product
Table 109. Ferrosan Medical Devices Recent Developments/Updates
Table 110. Advance Medical Solution Corporation Information
Table 111. Advance Medical Solution Description and Business Overview
Table 112. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Advance Medical Solution Surgical Hemostatic Agents Product
Table 114. Advance Medical Solution Recent Developments/Updates
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Business Overview
Table 117. Medtronic Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Medtronic Surgical Hemostatic Agents Product
Table 119. Medtronic Recent Developments/Updates
Table 120. Z-Medica Corporation Information
Table 121. Z-Medica Description and Business Overview
Table 122. Z-Medica Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Z-Medica Surgical Hemostatic Agents Product
Table 124. Z-Medica Recent Developments/Updates
Table 125. Marine Polymer Corporation Information
Table 126. Marine Polymer Description and Business Overview
Table 127. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Marine Polymer Surgical Hemostatic Agents Product
Table 129. Marine Polymer Recent Developments/Updates
Table 130. Equimedical Corporation Information
Table 131. Equimedical Description and Business Overview
Table 132. Equimedical Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Equimedical Surgical Hemostatic Agents Product
Table 134. Equimedical Recent Developments/Updates
Table 135. CryoLife Corporation Information
Table 136. CryoLife Description and Business Overview
Table 137. CryoLife Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. CryoLife Surgical Hemostatic Agents Product
Table 139. CryoLife Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Surgical Hemostatic Agents Distributors List
Table 143. Surgical Hemostatic Agents Customers List
Table 144. Surgical Hemostatic Agents Market Trends
Table 145. Surgical Hemostatic Agents Market Drivers
Table 146. Surgical Hemostatic Agents Market Challenges
Table 147. Surgical Hemostatic Agents Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
Table 1. Global Surgical Hemostatic Agents Market Value Comparison by Type (2023-2029) & (US$ Million)
Table 2. Global Surgical Hemostatic Agents Market Value Comparison by Application (2023-2029) & (US$ Million)
Table 3. Global Surgical Hemostatic Agents Market Competitive Situation by Manufacturers in 2022
Table 4. Global Surgical Hemostatic Agents Sales (K Units) of Key Manufacturers (2018-2023)
Table 5. Global Surgical Hemostatic Agents Sales Market Share by Manufacturers (2018-2023)
Table 6. Global Surgical Hemostatic Agents Revenue (US$ Million) by Manufacturers (2018-2023)
Table 7. Global Surgical Hemostatic Agents Revenue Share by Manufacturers (2018-2023)
Table 8. Global Market Surgical Hemostatic Agents Average Price (US$/Unit) of Key Manufacturers (2018-2023)
Table 9. Global Key Players of Surgical Hemostatic Agents, Industry Ranking, 2021 VS 2022 VS 2023
Table 10. Global Key Manufacturers of Surgical Hemostatic Agents, Manufacturing Sites & Headquarters
Table 11. Global Key Manufacturers of Surgical Hemostatic Agents, Product Type & Application
Table 12. Global Key Manufacturers of Surgical Hemostatic Agents, Date of Enter into This Industry
Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 14. Global Surgical Hemostatic Agents by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Surgical Hemostatic Agents as of 2022)
Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 16. Global Surgical Hemostatic Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Table 17. Global Surgical Hemostatic Agents Sales by Region (2018-2023) & (K Units)
Table 18. Global Surgical Hemostatic Agents Sales Market Share by Region (2018-2023)
Table 19. Global Surgical Hemostatic Agents Sales by Region (2024-2029) & (K Units)
Table 20. Global Surgical Hemostatic Agents Sales Market Share by Region (2024-2029)
Table 21. Global Surgical Hemostatic Agents Revenue by Region (2018-2023) & (US$ Million)
Table 22. Global Surgical Hemostatic Agents Revenue Market Share by Region (2018-2023)
Table 23. Global Surgical Hemostatic Agents Revenue by Region (2024-2029) & (US$ Million)
Table 24. Global Surgical Hemostatic Agents Revenue Market Share by Region (2024-2029)
Table 25. North America Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 26. North America Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 27. North America Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 28. North America Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 29. North America Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 30. Europe Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 31. Europe Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 32. Europe Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 33. Europe Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 34. Europe Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 35. Asia Pacific Surgical Hemostatic Agents Revenue by Region: 2018 VS 2022 VS 2029 (US$ Million)
Table 36. Asia Pacific Surgical Hemostatic Agents Sales by Region (2018-2023) & (K Units)
Table 37. Asia Pacific Surgical Hemostatic Agents Sales by Region (2024-2029) & (K Units)
Table 38. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2018-2023) & (US$ Million)
Table 39. Asia Pacific Surgical Hemostatic Agents Revenue by Region (2024-2029) & (US$ Million)
Table 40. Latin America Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 41. Latin America Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 42. Latin America Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 43. Latin America Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 44. Latin America Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 45. Middle East & Africa Surgical Hemostatic Agents Revenue by Country: 2018 VS 2022 VS 2029 (US$ Million)
Table 46. Middle East & Africa Surgical Hemostatic Agents Sales by Country (2018-2023) & (K Units)
Table 47. Middle East & Africa Surgical Hemostatic Agents Sales by Country (2024-2029) & (K Units)
Table 48. Middle East & Africa Surgical Hemostatic Agents Revenue by Country (2018-2023) & (US$ Million)
Table 49. Middle East & Africa Surgical Hemostatic Agents Revenue by Country (2024-2029) & (US$ Million)
Table 50. Global Surgical Hemostatic Agents Sales (K Units) by Type (2018-2023)
Table 51. Global Surgical Hemostatic Agents Sales (K Units) by Type (2024-2029)
Table 52. Global Surgical Hemostatic Agents Sales Market Share by Type (2018-2023)
Table 53. Global Surgical Hemostatic Agents Sales Market Share by Type (2024-2029)
Table 54. Global Surgical Hemostatic Agents Revenue (US$ Million) by Type (2018-2023)
Table 55. Global Surgical Hemostatic Agents Revenue (US$ Million) by Type (2024-2029)
Table 56. Global Surgical Hemostatic Agents Revenue Market Share by Type (2018-2023)
Table 57. Global Surgical Hemostatic Agents Revenue Market Share by Type (2024-2029)
Table 58. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2018-2023)
Table 59. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2024-2029)
Table 60. Global Surgical Hemostatic Agents Sales (K Units) by Application (2018-2023)
Table 61. Global Surgical Hemostatic Agents Sales (K Units) by Application (2024-2029)
Table 62. Global Surgical Hemostatic Agents Sales Market Share by Application (2018-2023)
Table 63. Global Surgical Hemostatic Agents Sales Market Share by Application (2024-2029)
Table 64. Global Surgical Hemostatic Agents Revenue (US$ Million) by Application (2018-2023)
Table 65. Global Surgical Hemostatic Agents Revenue (US$ Million) by Application (2024-2029)
Table 66. Global Surgical Hemostatic Agents Revenue Market Share by Application (2018-2023)
Table 67. Global Surgical Hemostatic Agents Revenue Market Share by Application (2024-2029)
Table 68. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2018-2023)
Table 69. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2024-2029)
Table 70. J&J Corporation Information
Table 71. J&J Description and Business Overview
Table 72. J&J Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 73. J&J Surgical Hemostatic Agents Product
Table 74. J&J Recent Developments/Updates
Table 75. Baxter Corporation Information
Table 76. Baxter Description and Business Overview
Table 77. Baxter Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 78. Baxter Surgical Hemostatic Agents Product
Table 79. Baxter Recent Developments/Updates
Table 80. BD Corporation Information
Table 81. BD Description and Business Overview
Table 82. BD Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 83. BD Surgical Hemostatic Agents Product
Table 84. BD Recent Developments/Updates
Table 85. Gelita Corporation Information
Table 86. Gelita Description and Business Overview
Table 87. Gelita Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 88. Gelita Surgical Hemostatic Agents Product
Table 89. Gelita Recent Developments/Updates
Table 90. Pfizer Corporation Information
Table 91. Pfizer Description and Business Overview
Table 92. Pfizer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 93. Pfizer Surgical Hemostatic Agents Product
Table 94. Pfizer Recent Developments/Updates
Table 95. B Braun Corporation Information
Table 96. B Braun Description and Business Overview
Table 97. B Braun Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 98. B Braun Surgical Hemostatic Agents Product
Table 99. B Braun Recent Developments/Updates
Table 100. CSL Behring Corporation Information
Table 101. CSL Behring Description and Business Overview
Table 102. CSL Behring Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 103. CSL Behring Surgical Hemostatic Agents Product
Table 104. CSL Behring Recent Developments/Updates
Table 105. Ferrosan Medical Devices Corporation Information
Table 106. Ferrosan Medical Devices Description and Business Overview
Table 107. Ferrosan Medical Devices Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 108. Ferrosan Medical Devices Surgical Hemostatic Agents Product
Table 109. Ferrosan Medical Devices Recent Developments/Updates
Table 110. Advance Medical Solution Corporation Information
Table 111. Advance Medical Solution Description and Business Overview
Table 112. Advance Medical Solution Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 113. Advance Medical Solution Surgical Hemostatic Agents Product
Table 114. Advance Medical Solution Recent Developments/Updates
Table 115. Medtronic Corporation Information
Table 116. Medtronic Description and Business Overview
Table 117. Medtronic Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 118. Medtronic Surgical Hemostatic Agents Product
Table 119. Medtronic Recent Developments/Updates
Table 120. Z-Medica Corporation Information
Table 121. Z-Medica Description and Business Overview
Table 122. Z-Medica Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 123. Z-Medica Surgical Hemostatic Agents Product
Table 124. Z-Medica Recent Developments/Updates
Table 125. Marine Polymer Corporation Information
Table 126. Marine Polymer Description and Business Overview
Table 127. Marine Polymer Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 128. Marine Polymer Surgical Hemostatic Agents Product
Table 129. Marine Polymer Recent Developments/Updates
Table 130. Equimedical Corporation Information
Table 131. Equimedical Description and Business Overview
Table 132. Equimedical Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 133. Equimedical Surgical Hemostatic Agents Product
Table 134. Equimedical Recent Developments/Updates
Table 135. CryoLife Corporation Information
Table 136. CryoLife Description and Business Overview
Table 137. CryoLife Surgical Hemostatic Agents Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2023)
Table 138. CryoLife Surgical Hemostatic Agents Product
Table 139. CryoLife Recent Developments/Updates
Table 140. Key Raw Materials Lists
Table 141. Raw Materials Key Suppliers Lists
Table 142. Surgical Hemostatic Agents Distributors List
Table 143. Surgical Hemostatic Agents Customers List
Table 144. Surgical Hemostatic Agents Market Trends
Table 145. Surgical Hemostatic Agents Market Drivers
Table 146. Surgical Hemostatic Agents Market Challenges
Table 147. Surgical Hemostatic Agents Market Restraints
Table 148. Research Programs/Design for This Report
Table 149. Key Data Information from Secondary Sources
Table 150. Key Data Information from Primary Sources
LIST OF FIGURES
Figure 1. Product Picture of Surgical Hemostatic Agents
Figure 2. Global Surgical Hemostatic Agents Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Surgical Hemostatic Agents Market Share by Type in 2022 & 2029
Figure 4. Gelation Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Others Product Picture
Figure 7. Global Surgical Hemostatic Agents Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Surgical Hemostatic Agents Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Surgical Centers
Figure 11. Other
Figure 12. Global Surgical Hemostatic Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Surgical Hemostatic Agents Market Size (2018-2029) & (US$ Million)
Figure 14. Global Surgical Hemostatic Agents Sales (2018-2029) & (K Units)
Figure 15. Global Surgical Hemostatic Agents Average Price (US$/Unit) & (2018-2029)
Figure 16. Surgical Hemostatic Agents Report Years Considered
Figure 17. Surgical Hemostatic Agents Sales Share by Manufacturers in 2022
Figure 18. Global Surgical Hemostatic Agents Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Surgical Hemostatic Agents Players: Market Share by Revenue in 2022
Figure 20. Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Surgical Hemostatic Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 23. North America Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 24. United States Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 27. Europe Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 28. Germany Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Surgical Hemostatic Agents Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Surgical Hemostatic Agents Revenue Market Share by Region (2018-2029)
Figure 35. China Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 45. Latin America Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Surgical Hemostatic Agents by Type (2018-2029)
Figure 56. Global Revenue Market Share of Surgical Hemostatic Agents by Type (2018-2029)
Figure 57. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Surgical Hemostatic Agents by Application (2018-2029)
Figure 59. Global Revenue Market Share of Surgical Hemostatic Agents by Application (2018-2029)
Figure 60. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2018-2029)
Figure 61. Surgical Hemostatic Agents Value Chain
Figure 62. Surgical Hemostatic Agents Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
Figure 1. Product Picture of Surgical Hemostatic Agents
Figure 2. Global Surgical Hemostatic Agents Market Value Comparison by Type (2023-2029) & (US$ Million)
Figure 3. Global Surgical Hemostatic Agents Market Share by Type in 2022 & 2029
Figure 4. Gelation Hemostats Product Picture
Figure 5. Combination Hemostats Product Picture
Figure 6. Others Product Picture
Figure 7. Global Surgical Hemostatic Agents Market Value Comparison by Application (2023-2029) & (US$ Million)
Figure 8. Global Surgical Hemostatic Agents Market Share by Application in 2022 & 2029
Figure 9. Hospitals
Figure 10. Surgical Centers
Figure 11. Other
Figure 12. Global Surgical Hemostatic Agents Revenue, (US$ Million), 2018 VS 2022 VS 2029
Figure 13. Global Surgical Hemostatic Agents Market Size (2018-2029) & (US$ Million)
Figure 14. Global Surgical Hemostatic Agents Sales (2018-2029) & (K Units)
Figure 15. Global Surgical Hemostatic Agents Average Price (US$/Unit) & (2018-2029)
Figure 16. Surgical Hemostatic Agents Report Years Considered
Figure 17. Surgical Hemostatic Agents Sales Share by Manufacturers in 2022
Figure 18. Global Surgical Hemostatic Agents Revenue Share by Manufacturers in 2022
Figure 19. The Global 5 and 10 Largest Surgical Hemostatic Agents Players: Market Share by Revenue in 2022
Figure 20. Surgical Hemostatic Agents Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2018 VS 2022
Figure 21. Global Surgical Hemostatic Agents Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
Figure 22. North America Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 23. North America Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 24. United States Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 25. Canada Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 26. Europe Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 27. Europe Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 28. Germany Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 29. France Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 30. U.K. Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 31. Italy Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 32. Russia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 33. Asia Pacific Surgical Hemostatic Agents Sales Market Share by Region (2018-2029)
Figure 34. Asia Pacific Surgical Hemostatic Agents Revenue Market Share by Region (2018-2029)
Figure 35. China Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 36. Japan Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 37. South Korea Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 38. India Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 39. Australia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 40. China Taiwan Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 41. Indonesia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 42. Thailand Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 43. Malaysia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 44. Latin America Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 45. Latin America Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 46. Mexico Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 47. Brazil Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 48. Argentina Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 49. Colombia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 50. Middle East & Africa Surgical Hemostatic Agents Sales Market Share by Country (2018-2029)
Figure 51. Middle East & Africa Surgical Hemostatic Agents Revenue Market Share by Country (2018-2029)
Figure 52. Turkey Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 53. Saudi Arabia Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 54. UAE Surgical Hemostatic Agents Revenue Growth Rate (2018-2029) & (US$ Million)
Figure 55. Global Sales Market Share of Surgical Hemostatic Agents by Type (2018-2029)
Figure 56. Global Revenue Market Share of Surgical Hemostatic Agents by Type (2018-2029)
Figure 57. Global Surgical Hemostatic Agents Price (US$/Unit) by Type (2018-2029)
Figure 58. Global Sales Market Share of Surgical Hemostatic Agents by Application (2018-2029)
Figure 59. Global Revenue Market Share of Surgical Hemostatic Agents by Application (2018-2029)
Figure 60. Global Surgical Hemostatic Agents Price (US$/Unit) by Application (2018-2029)
Figure 61. Surgical Hemostatic Agents Value Chain
Figure 62. Surgical Hemostatic Agents Production Process
Figure 63. Channels of Distribution (Direct Vs Distribution)
Figure 64. Distributors Profiles
Figure 65. Bottom-up and Top-down Approaches for This Report
Figure 66. Data Triangulation
Figure 67. Key Executives Interviewed
